NDAOTICSOLUTION/DROPS
Approved
May 2009
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
3/8 — Basic
CETRAXAL (ciprofloxacin hydrochloride) by Salvat is (see 12. Approved for mycobacterium avium complex infection, hiv infection. First approved in 2009.
Drug data last refreshed 20h ago
Mechanism of Action
(see 12.4 Clinical Pharmacology, Microbiology).
Worked on CETRAXAL at Salvat? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.